高级检索
当前位置: 首页 > 详情页

Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C ◇ 卓越:领军期刊

机构: [1]Department of Cardiology, Daping Hospital, the Third Military Medical University (Army Medical University), Chongqing 400042, China. [2]Key Laboratory of Geriatric Cardiovascular and Cerebrovascular Disease Research, Ministry of Education of China, Chongqing Key Laboratory for Hypertension Research, Chongqing Cardiovascular Clinical Research Center, Chongqing Institute of Cardiology, Chongqing 400042, China. [3]Department of Cardiovascular Medicine, the General Hospital of Western Theater Command, Chengdu 610083, China. [4]Division of Renal Diseases and Hypertension, the George Washington University School of Medicine and Health Sciences, Washington, DC 20541, USA. [5]State Key Laboratory of Trauma, Burns and Combined Injury, Daping Hospital, the Third Military Medical University, Chongqing 400042, China. [6]Cardiovascular Research Center of Chongqing College, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Chongqing 400042, China. [7]Department of Cardiology, the First Affiliated Hospital of Kunming Medical University, Kunming 650000, China.
出处:
ISSN:

关键词: Metabolic reprogramming Cardiomyocyte proliferation Carnitine palmitoyltransferase 1 Etomoxir Fatty acid oxidation Glycolysis ADP-ribosylation p38 MAPK

摘要:
The neonatal mammalian heart has a remarkable regenerative capacity, while the adult heart has difficulty to regenerate. A metabolic reprogramming from glycolysis to fatty acid oxidation occurs along with the loss of cardiomyocyte proliferative capacity shortly after birth. In this study, we sought to determine if and how metabolic reprogramming regulates cardiomyocyte proliferation. Reversing metabolic reprogramming by carnitine palmitoyltransferase 1 (CPT1) inhibition, using cardiac-specific Cpt1a and Cpt1b knockout mice promoted cardiomyocyte proliferation and improved cardiac function post-myocardial infarction. The inhibition of CPT1 is of pharmacological significance because those protective effects were replicated by etomoxir, a CPT1 inhibitor. CPT1 inhibition, by decreasing poly(ADP-ribose) polymerase 1 expression, reduced ADP-ribosylation of dual-specificity phosphatase 1 in cardiomyocytes, leading to decreased p38 MAPK phosphorylation, and stimulation of cardiomyocyte proliferation. Our present study indicates that reversing metabolic reprogramming is an effective strategy to stimulate adult cardiomyocyte proliferation. CPT1 is a potential therapeutic target for promoting heart regeneration and myocardial infarction treatment.© 2025 The Authors.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2026]版:
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 药学
JCR分区:
出版当年[2025]版:
最新[2024]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2025版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Department of Cardiology, Daping Hospital, the Third Military Medical University (Army Medical University), Chongqing 400042, China. [2]Key Laboratory of Geriatric Cardiovascular and Cerebrovascular Disease Research, Ministry of Education of China, Chongqing Key Laboratory for Hypertension Research, Chongqing Cardiovascular Clinical Research Center, Chongqing Institute of Cardiology, Chongqing 400042, China. [3]Department of Cardiovascular Medicine, the General Hospital of Western Theater Command, Chengdu 610083, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Cardiology, Daping Hospital, the Third Military Medical University (Army Medical University), Chongqing 400042, China. [2]Key Laboratory of Geriatric Cardiovascular and Cerebrovascular Disease Research, Ministry of Education of China, Chongqing Key Laboratory for Hypertension Research, Chongqing Cardiovascular Clinical Research Center, Chongqing Institute of Cardiology, Chongqing 400042, China. [5]State Key Laboratory of Trauma, Burns and Combined Injury, Daping Hospital, the Third Military Medical University, Chongqing 400042, China. [6]Cardiovascular Research Center of Chongqing College, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Chongqing 400042, China. [7]Department of Cardiology, the First Affiliated Hospital of Kunming Medical University, Kunming 650000, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:70796 今日访问量:0 总访问量:2273 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司